Ultra-fast vitrification of patient-derived circulating tumor cell lines

Emerging technologies have enabled the isolation and characterization of rare circulating tumor cells (CTCs) from the blood of metastatic cancer patients. CTCs represent a non-invasive opportunity to gain information regarding the primary tumor and recent reports suggest CTCs have value as an indicator of disease status. CTCs are fragile and difficult to expand in vitro, so typically molecular characterization must be performed immediately following isolation. To ease experimental timelines and enable biobanking, cryopreservation methods are needed. However, extensive cellular heterogeneity and the rarity of CTCs complicates the optimization of cryopreservation methods based upon cell type, necessitating a standardized protocol. Here, we optimized a previously reported vitrification protocol to preserve patient-derived CTC cell lines using highly conductive silica microcapillaries to achieve ultra-fast cooling rates with low cryoprotectant concentrations. Using this vitrification protocol, five CTC cell lines were cooled to cryogenic temperatures. Thawed CTCs exhibited high cell viability and expanded under in vitro cell culture conditions. EpCAM biomarker expression was maintained for each CTC cell line. One CTC cell line was selected for molecular characterization, revealing that RNA integrity was maintained after storage. A qPCR panel showed no significant difference in thawed CTCs compared to fresh controls. The data presented here suggests vitrification may enable the standardization of cryopreservation methods for CTCs.

• Publication year

  2018

• Venue

  PLoS ONE

• Publication date

  2018-02-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pone.0192734PMID 29474365PMCID 5825040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack

  2016cited by this paper
• Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

  2016cited by this paper
• "Universal" vitrification of cells by ultra-fast cooling.

  2015influential reference
• Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics

  2015cited by this paper
• Biobanking for Personalized Medicine.

  2015cited by this paper
• Microfluidic, marker-free isolation of circulating tumor cells from blood samples

  2014cited by this paper
• Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

  2014cited by this paper
• Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

  2014influential reference
• Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.

  2014cited by this paper
• Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells

  2013cited by this paper
• Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

  2013cited by this paper
• Isolation and retrieval of circulating tumor cells using centrifugal forces

  2013cited by this paper
• Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer

  2012cited by this paper
• Biorepositories: Building better biobanks

  2012cited by this paper
• Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

  2012cited by this paper
• Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

  2010cited by this paper
• Molecular Biomarker Analyses Using Circulating Tumor Cells

  2010cited by this paper
• Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

  2010cited by this paper
• Cryopreservation and banking of mammalian cell lines

  2008cited by this paper
• Detection of mutations in EGFR in circulating lung-cancer cells.

  2008cited by this paper
• Thermal performance of quartz capillaries for vitrification.

  2007cited by this paper
• Optimising cryopreservation protocols for haematopoietic progenitor cells: a methodological approach for umbilical cord blood.

  2006cited by this paper
• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

  2004cited by this paper
• Improved vitrification solutions based on the predictability of vitrification solution toxicity.

  2004cited by this paper
• Long-term storage of tissues by cryopreservation: critical issues.

  1996cited by this paper
• Cryobiology: the freezing of biological systems.

  1970cited by this paper

• Reconstructing the metastatic journey: functional circulating tumor cells and disseminated tumor cells based models for translational oncology

  2026cites this paper
• Validation of a high-throughput screening assay for the characterization of cryoprotective agent toxicity

  2025cites this paper
• Models to study CTCs and CTC culture methods.

  2023cites this paper
• Facial cosmetic injection: A bibliometric analysis of research status and hotspots

  2023cites this paper
• Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved

  2022cites this paper
• Personalized Models of Human PDAC

  2020cites this paper
• Low cryoprotectant concentration rapid vitrification of mouse oocytes and embryos.

  2020cites this paper
• Automated molecular-image cytometry and analysis in modern oncology

  2020cites this paper
• Cryopreservation of infectious Cryptosporidiumparvum oocysts

  2018cites this paper